INT Medical (Shanghai INT Medical Instruments Co., Ltd.; 01501) gained full shareholder approval for a series of governance resolutions at its first extraordinary general meeting (EGM) of 2026, held on 24 September in Shanghai. All five motions—three ordinary and two special resolutions—were passed by poll.
The company reported that 146.09 million shares, representing 69.17% of its 211.20 million issued H shares, were voted. The H-share trustee, holding 4.36 million shares (2.06% of issued stock), abstained from voting in line with Hong Kong Listing Rule 17.05A. On Resolution 3, which sought to raise the individual limit for Chairman Dr. Liang Dongke under the H-Share Award and Trust Scheme, Dr. Liang and related parties (21.94 million shares) abstained, leaving 184.90 million shares eligible; the motion still secured 99.73% approval.
Key outcomes:
• Director appointments (Ordinary Resolutions 1 & 2): Dr. Zhang Peng and Dr. Lai Wan Lung were elected as independent non-executive directors (INEDs) of the fourth board session, each receiving 100% of the 146.09 million votes cast.
• Share-based incentive adjustment (Ordinary Resolution 3): Shareholders authorized an increase in Dr. Liang Dongke’s individual limit under the H-Share Award and Trust Scheme with 123.82 million votes in favour (99.73%).
• Corporate governance updates (Special Resolutions 4 & 5): Amendments to the Articles of Association and the Board’s Rules of Procedure each passed unanimously with 146.09 million affirmative votes.
Following the appointments, Mr. Jian Xigao and Mr. Hui Hung Kwan stepped down as INEDs and vacated their committee roles. Concurrently, the Board re-constituted its committees effective 24 September 2026:
1. Audit Committee – Mr. Xu Congli (Chair), Dr. Lai Wan Lung, and employee-representative director Ms. Chen Jie now serve as members. 2. Remuneration Committee – Dr. Lai Wan Lung (Chair) and Mr. Xu Congli are members. 3. Nomination Committee – Dr. Zhang Peng (Chair) and Mr. Xu Congli are members. 4. Strategy and Sustainability Committee – newly established, chaired by Dr. Liang Dongke with Dr. Zhang Peng and Dr. Lai Wan Lung as members.
INT Medical confirms that all meeting procedures complied with PRC Company Law, its Articles of Association, and Hong Kong Listing Rules.
Comments